Inactive Instrument
Probi AB Stock OTC Markets
Stocks
PBBIF
SE0001280355
Pharmaceuticals
OTC Markets Traded| 1 day | +31.67% |
| Manager | Title | Age | Since |
|---|---|---|---|
Anita Johansen
CEO | Chief Executive Officer | 54 | 08/12/2022 |
Johan Flink
DFI | Director of Finance/CFO | 49 | 01/08/2025 |
James Henson
COO | Chief Operating Officer | 39 | 01/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Jörn Andreas
BRD | Director/Board Member | 45 | 01/01/2014 |
| Chairman | 62 | 01/04/2015 | |
| Director/Board Member | 64 | 04/05/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +31.67% | +85.88% | - | - | 33.68M | ||
| +0.86% | +1.43% | +47.17% | +163.68% | 1,067B | ||
| +1.59% | +4.09% | +56.51% | +52.50% | 635B | ||
| +0.95% | +1.91% | +36.30% | +82.78% | 458B | ||
| +1.60% | +6.25% | +37.00% | +31.03% | 347B | ||
| -0.60% | +1.52% | +36.67% | +41.41% | 295B | ||
| -0.14% | +0.60% | +17.29% | +18.74% | 262B | ||
| +0.09% | -2.82% | -29.09% | -39.57% | 216B | ||
| +1.22% | +2.66% | +22.66% | +59.87% | 203B | ||
| -1.18% | -3.70% | +11.28% | +67.52% | 161B | ||
| Average | +3.61% | +1.33% | +26.20% | +53.11% | 404.83B | |
| Weighted average by Cap. | +0.76% | +1.95% | +35.99% | +79.10% |
Employees
-
Sector
Pharmaceuticals
















